FDA product code ORH: Lamotrigine Assay

ORH is the FDA product code for lamotrigine assay. It is a Class II device, regulated under 21 CFR 862.3350 and reviewed by the Clinical Toxicology panel. FDA has cleared 2 510(k) submissions under ORH, from 2 different applicants. The average 510(k) review took 138 days (median 138).

Definition

for the quantitative determination of lamotrigine in human serum or plasma on automated clinical chemistry analyzers.

Classification

FieldValue
Device nameLamotrigine Assay
Device classClass II
Regulation21 CFR 862.3350
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Top ORH applicants

ApplicantClearancesLatest
Ark Diagnostics, Inc.12010-10-29
Seradyn, Inc.12007-01-12

Most recent ORH clearances

510(k)ApplicantDeviceDecision dateReview days
K101305Ark Diagnostics, Inc.ARK LAMOTRIGINE ASSAY, CALIBRATOR & CONTROL2010-10-29172
K062966Seradyn, Inc.QMS LAMOTRIGINE ASSAY (REAGENTS), CALIBRATORS & CONTROLS2007-01-12105

Recalls for ORH devices

openFDA lists no recalls for product code ORH.

Frequently asked questions

What is FDA product code ORH?

ORH is the FDA product code for lamotrigine assay. It is a Class II device, regulated under 21 CFR 862.3350 and reviewed by the Clinical Toxicology panel.

What device class is ORH?

Class II, regulation 21 CFR 862.3350. Typical premarket route: 510(k).

How long does a 510(k) take for product code ORH?

Across 2 cleared submissions the average was 138 days from receipt to decision (median 138).

Which companies have the most ORH clearances?

Ark Diagnostics, Inc. (1); Seradyn, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup